Align Technology (Santa Clara, California) reported a new addition to its Invisalign product family: Invisalign Teen for non-adult, comprehensive orthodontic treatment. According to consumer research conducted by Align, orthodontists cited patient compliance as their number one concern when treating teen patients. In response, Align designed Invisalign Teen aligners with compliance indicators that provide a visual cue of approximate patient wear. When worn as directed, the indicators fade from dark to light blue or clear during the two week wear period for each set of aligners — providing doctors, parents and patients with a visible monitor of compliance. Align Technology makes Invisalign, a method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position.
Dormio Tech (Chatsworth, California), a division of CHAD Therapeutics, said that it received FDA clearance to market the company's FloChannel diagnostic system, Dormio's first product for the large and rapidly growing sleep disorder market. Dormio Tech's FloChannel is a diagnostic device that independently monitors left and right nasal airflow. This allows the system to detect and measure nasal cycling (the periodic alternation in nasal airflow resistance between the two nasal cavities), as well as oral airflow and snoring, and provides constant baseline airflow volumetric sleep scoring. The patented device connects easily to standard sleep lab systems. CHAD Therapeutics makes products for the sleep disorder market.